Inhibrx Biosciences, Inc. INBX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $161.66M-25.3% | $124.22M-18.6% | $153.09M-22.0% | $186.57M-17.8% | $216.52M-14.2% | ||
| $171.34M-23.3% | $132.83M— | $161.42M— | $193.96M— | $223.39M— | ||
| $3.2M-42.4% | $3.73M— | $4.31M— | $4.89M— | $5.55M— | ||
| $183.97M-24.2% | $146.48M— | $177.47M— | $212.12M— | $242.64M— | ||
| $29.77M-31.6% | $29.9M-22.7% | $33.2M-17.8% | $38.8M+46.8% | $43.53M— | ||
| $26.51M-39.2% | $33.8M— | $35.98M— | $38.94M— | $43.64M— | ||
| $174.99M+77.4% | $100.56M— | $99.92M— | $99.28M— | $98.65M— | ||
| $205M+38.3% | $138.49M— | $140.64M— | $143.56M— | $148.2M— | ||
| 120M0.0% | 120M— | 120M— | 120M— | 120M— | ||
| -$279.63M-87.1% | -$246.19M— | -$213.35M— | -$178.1M— | -$149.44M— | ||
| -$21.04M-122% | $7.99M-94.0% | $36.83M-79.4% | $68.56M-68.7% | $94.44M+716% | ||
| $183.97M-24.2% | $146.48M— | $177.47M— | $212.12M— | $242.64M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Inhibrx Biosciences, Inc.'s total assets?
- Inhibrx Biosciences, Inc. (INBX) holds $184.0M in total assets, down 24.2% year over year.
- How much debt does Inhibrx Biosciences, Inc. have?
- Inhibrx Biosciences, Inc. carries $180.9M in total debt against -$21.0M of shareholders' equity, a debt-to-equity ratio of 13.39.
- How much cash does Inhibrx Biosciences, Inc. have?
- Inhibrx Biosciences, Inc. holds $161.7M in cash and equivalents.
- Can Inhibrx Biosciences, Inc. cover its short-term obligations?
- Its current ratio is 6.46 — current assets exceed current liabilities.
- Where does Inhibrx Biosciences, Inc.'s balance sheet data come from?
- Every line is extracted from Inhibrx Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
